A detailed history of Two Sigma Investments, LP transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 177,420 shares of MORF stock, worth $10.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
177,420
Previous 256,751 30.9%
Holding current value
$10.1 Million
Previous $9.04 Million 33.12%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$26.12 - $34.07 $2.07 Million - $2.7 Million
-79,331 Reduced 30.9%
177,420 $6.04 Million
Q1 2024

May 15, 2024

SELL
$26.64 - $40.31 $5.86 Million - $8.87 Million
-220,116 Reduced 46.16%
256,751 $9.04 Million
Q4 2023

Feb 14, 2024

BUY
$19.95 - $31.0 $1.25 Million - $1.94 Million
62,625 Added 15.12%
476,867 $13.8 Million
Q3 2023

Nov 14, 2023

BUY
$21.33 - $59.42 $8.54 Million - $23.8 Million
400,142 Added 2837.89%
414,242 $9.49 Million
Q2 2023

Aug 14, 2023

BUY
$34.33 - $62.11 $85,825 - $155,275
2,500 Added 21.55%
14,100 $808,000
Q1 2023

May 15, 2023

SELL
$26.01 - $48.69 $54,621 - $102,249
-2,100 Reduced 15.33%
11,600 $436,000
Q4 2022

Feb 14, 2023

BUY
$24.14 - $30.37 $330,718 - $416,069
13,700 New
13,700 $366,000
Q2 2022

Aug 15, 2022

BUY
$19.74 - $43.01 $1.59 Million - $3.47 Million
80,754 New
80,754 $1.75 Million
Q1 2022

May 16, 2022

SELL
$36.25 - $52.02 $166,750 - $239,292
-4,600 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$43.27 - $65.72 $110,035 - $167,125
-2,543 Reduced 35.6%
4,600 $218,000
Q3 2021

Nov 15, 2021

SELL
$53.61 - $67.5 $505,113 - $635,985
-9,422 Reduced 56.88%
7,143 $405,000
Q2 2021

Aug 16, 2021

SELL
$45.13 - $64.99 $1.93 Million - $2.78 Million
-42,790 Reduced 72.09%
16,565 $951,000
Q1 2021

May 17, 2021

BUY
$29.77 - $84.85 $926,382 - $2.64 Million
31,118 Added 110.2%
59,355 $3.76 Million
Q4 2020

Feb 16, 2021

BUY
$25.66 - $34.55 $724,561 - $975,588
28,237 New
28,237 $947,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.